Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 67 entries
Sorted by: Best Match Show Resources per page
Nickel-cobalt hydroxide nanosheets: Synthesis, morphology and electrochemical properties.

Journal of colloid and interface science

Schneiderová B, Demel J, Zhigunov A, Bohuslav J, Tarábková H, Janda P, Lang K.
PMID: 28365439
J Colloid Interface Sci. 2017 Aug 01;499:138-144. doi: 10.1016/j.jcis.2017.03.096. Epub 2017 Mar 25.

This paper reports the synthesis, characterization, and electrochemical performance of nickel-cobalt hydroxide nanosheets. The hydroxide nanosheets of approximately 0.7nm thickness were prepared by delamination of layered nickel-cobalt hydroxide lactate in water and formed transparent colloids that were stable for...

Cite
Schneiderová B, Demel J, Zhigunov A, et al. Nickel-cobalt hydroxide nanosheets: Synthesis, morphology and electrochemical properties. J Colloid Interface Sci. 2017;499:138-144doi: 10.1016/j.jcis.2017.03.096.
Schneiderová, B., Demel, J., Zhigunov, A., Bohuslav, J., Tarábková, H., Janda, P., & Lang, K. (2017). Nickel-cobalt hydroxide nanosheets: Synthesis, morphology and electrochemical properties. Journal of colloid and interface science, 499138-144. https://doi.org/10.1016/j.jcis.2017.03.096
Schneiderová, Barbora, et al. "Nickel-cobalt hydroxide nanosheets: Synthesis, morphology and electrochemical properties." Journal of colloid and interface science vol. 499 (2017): 138-144. doi: https://doi.org/10.1016/j.jcis.2017.03.096
Schneiderová B, Demel J, Zhigunov A, Bohuslav J, Tarábková H, Janda P, Lang K. Nickel-cobalt hydroxide nanosheets: Synthesis, morphology and electrochemical properties. J Colloid Interface Sci. 2017 Aug 01;499:138-144. doi: 10.1016/j.jcis.2017.03.096. Epub 2017 Mar 25. PMID: 28365439.
Copy Download .nbib Format: NLM
Regional differentiation and extensive hybridization between mitochondrial clades of the Southern Ocean giant sea spider Colossendeis megalonyx.

Royal Society open science

Dietz L, Arango CP, Dömel JS, Halanych KM, Harder AM, Held C, Mahon AR, Mayer C, Melzer RR, Rouse GW, Weis A, Wilson NG, Leese F.
PMID: 26587257
R Soc Open Sci. 2015 Jul 29;2(7):140424. doi: 10.1098/rsos.140424. eCollection 2015 Jul.

Assessing the enormous diversity of Southern Ocean benthic species and their evolutionary histories is a central task in the era of global climate change. Based on mitochondrial markers, it was recently suggested that the circumpolar giant sea spider Colossendeis...

Cite
Dietz L, Arango CP, Dömel JS, et al. Regional differentiation and extensive hybridization between mitochondrial clades of the Southern Ocean giant sea spider Colossendeis megalonyx. R Soc Open Sci. 2015;2(7):140424doi: 10.1098/rsos.140424.
Dietz, L., Arango, C. P., Dömel, J. S., Halanych, K. M., Harder, A. M., Held, C., Mahon, A. R., Mayer, C., Melzer, R. R., Rouse, G. W., Weis, A., Wilson, N. G., & Leese, F. (2015). Regional differentiation and extensive hybridization between mitochondrial clades of the Southern Ocean giant sea spider Colossendeis megalonyx. Royal Society open science, 2(7), 140424. https://doi.org/10.1098/rsos.140424
Dietz, Lars, et al. "Regional differentiation and extensive hybridization between mitochondrial clades of the Southern Ocean giant sea spider Colossendeis megalonyx." Royal Society open science vol. 2,7 (2015): 140424. doi: https://doi.org/10.1098/rsos.140424
Dietz L, Arango CP, Dömel JS, Halanych KM, Harder AM, Held C, Mahon AR, Mayer C, Melzer RR, Rouse GW, Weis A, Wilson NG, Leese F. Regional differentiation and extensive hybridization between mitochondrial clades of the Southern Ocean giant sea spider Colossendeis megalonyx. R Soc Open Sci. 2015 Jul 29;2(7):140424. doi: 10.1098/rsos.140424. eCollection 2015 Jul. PMID: 26587257; PMCID: PMC4632570.
Copy Download .nbib Format: NLM
Synthesis, coordination and catalytic use of 1-(diphenylphosphino)-1'-carbamoylferrocenes with pyridyl-containing N-substituents.

Dalton transactions (Cambridge, England : 2003)

Kühnert J, Dusek M, Demel J, Lang H, Stepnicka P.
PMID: 17592597
Dalton Trans. 2007 Jul 14;(26):2802-11. doi: 10.1039/b701012e. Epub 2007 May 04.

Ferrocene phosphinocarboxamides, 1-(diphenylphosphino)-1'-{N-[(2-pyridyl)methyl]carbamoyl}ferrocene (1) and 1-(diphenylphosphino)-1'-{N-[2-(2-pyridyl)ethyl]carbamoyl}ferrocene (2) were prepared from 1-(diphenylphosphino)-1'-ferrocenecarboxylic acid and studied as ligands for palladium. Starting with [PdCl2(cod)], the reactions at a 2 : 1 ligand-to-metal ratio gave uniformly the bis-phosphine complexes [PdCl2(L-kappaP)2] (3, L =...

Cite
Kühnert J, Dusek M, Demel J, et al. Synthesis, coordination and catalytic use of 1-(diphenylphosphino)-1'-carbamoylferrocenes with pyridyl-containing N-substituents. Dalton Trans. 2007;(26):2802-11doi: 10.1039/b701012e.
Kühnert, J., Dusek, M., Demel, J., Lang, H., & Stepnicka, P. (2007). Synthesis, coordination and catalytic use of 1-(diphenylphosphino)-1'-carbamoylferrocenes with pyridyl-containing N-substituents. Dalton transactions (Cambridge, England : 2003), (26), 2802-11. https://doi.org/10.1039/b701012e
Kühnert, Janett, et al. "Synthesis, coordination and catalytic use of 1-(diphenylphosphino)-1'-carbamoylferrocenes with pyridyl-containing N-substituents." Dalton transactions (Cambridge, England : 2003) vol. ,26 (2007): 2802-11. doi: https://doi.org/10.1039/b701012e
Kühnert J, Dusek M, Demel J, Lang H, Stepnicka P. Synthesis, coordination and catalytic use of 1-(diphenylphosphino)-1'-carbamoylferrocenes with pyridyl-containing N-substituents. Dalton Trans. 2007 Jul 14;(26):2802-11. doi: 10.1039/b701012e. Epub 2007 May 04. PMID: 17592597.
Copy Download .nbib Format: NLM
Combining morphological and genomic evidence to resolve species diversity and study speciation processes of the .

Frontiers in zoology

Dömel JS, Macher TH, Dietz L, Duncan S, Mayer C, Rozenberg A, Wolcott K, Leese F, Melzer RR.
PMID: 31516540
Front Zool. 2019 Sep 06;16:36. doi: 10.1186/s12983-019-0316-y. eCollection 2019.

RESULTS: Phylogenomic results support most of the previously reported lineages within the CONCLUSIONS: We generated an unprecedented molecular data set for members of the

Cite
Dömel JS, Macher TH, Dietz L, et al. Combining morphological and genomic evidence to resolve species diversity and study speciation processes of the . Front Zool. 2019;16:36doi: 10.1186/s12983-019-0316-y.
Dömel, J. S., Macher, T. H., Dietz, L., Duncan, S., Mayer, C., Rozenberg, A., Wolcott, K., Leese, F., & Melzer, R. R. (2019). Combining morphological and genomic evidence to resolve species diversity and study speciation processes of the . Frontiers in zoology, 1636. https://doi.org/10.1186/s12983-019-0316-y
Dömel, Jana S, et al. "Combining morphological and genomic evidence to resolve species diversity and study speciation processes of the ." Frontiers in zoology vol. 16 (2019): 36. doi: https://doi.org/10.1186/s12983-019-0316-y
Dömel JS, Macher TH, Dietz L, Duncan S, Mayer C, Rozenberg A, Wolcott K, Leese F, Melzer RR. Combining morphological and genomic evidence to resolve species diversity and study speciation processes of the . Front Zool. 2019 Sep 06;16:36. doi: 10.1186/s12983-019-0316-y. eCollection 2019. PMID: 31516540; PMCID: PMC6728986.
Copy Download .nbib Format: NLM
A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States.

MDM policy & practice

Swan JS, Lennes IT, Stump NN, Temel JS, Wang D, Keller L, Donelan K.
PMID: 30349874
MDM Policy Pract. 2018 Oct 15;3(2):2381468318801565. doi: 10.1177/2381468318801565. eCollection 2018.

No abstract available.

Cite
Swan JS, Lennes IT, Stump NN, et al. A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States. MDM Policy Pract. 2018;3(2):2381468318801565doi: 10.1177/2381468318801565.
Swan, J. S., Lennes, I. T., Stump, N. N., Temel, J. S., Wang, D., Keller, L., & Donelan, K. (2018). A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States. MDM policy & practice, 3(2), 2381468318801565. https://doi.org/10.1177/2381468318801565
Swan, J Shannon, et al. "A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States." MDM policy & practice vol. 3,2 (2018): 2381468318801565. doi: https://doi.org/10.1177/2381468318801565
Swan JS, Lennes IT, Stump NN, Temel JS, Wang D, Keller L, Donelan K. A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States. MDM Policy Pract. 2018 Oct 15;3(2):2381468318801565. doi: 10.1177/2381468318801565. eCollection 2018. PMID: 30349874; PMCID: PMC6194926.
Copy Download .nbib Format: NLM
Phosphinic Acid Based Linkers: Building Blocks in Metal-Organic Framework Chemistry.

Angewandte Chemie (International ed. in English)

Hynek J, Brázda P, Rohlíček J, Londesborough MGS, Demel J.
PMID: 29451728
Angew Chem Int Ed Engl. 2018 Apr 23;57(18):5016-5019. doi: 10.1002/anie.201800884. Epub 2018 Mar 23.

Metal-organic frameworks (MOFs) are a chemically and topologically diverse family of materials composed of inorganic nodes and organic linkers bound together by coordination bonds. Presented here are two significant innovations in this field. The first is the use of...

Cite
Hynek J, Brázda P, Rohlíček J, et al. Phosphinic Acid Based Linkers: Building Blocks in Metal-Organic Framework Chemistry. Angew Chem Int Ed Engl. 2018;57(18):5016-5019doi: 10.1002/anie.201800884.
Hynek, J., Brázda, P., Rohlíček, J., Londesborough, M. G. S., & Demel, J. (2018). Phosphinic Acid Based Linkers: Building Blocks in Metal-Organic Framework Chemistry. Angewandte Chemie (International ed. in English), 57(18), 5016-5019. https://doi.org/10.1002/anie.201800884
Hynek, Jan, et al. "Phosphinic Acid Based Linkers: Building Blocks in Metal-Organic Framework Chemistry." Angewandte Chemie (International ed. in English) vol. 57,18 (2018): 5016-5019. doi: https://doi.org/10.1002/anie.201800884
Hynek J, Brázda P, Rohlíček J, Londesborough MGS, Demel J. Phosphinic Acid Based Linkers: Building Blocks in Metal-Organic Framework Chemistry. Angew Chem Int Ed Engl. 2018 Apr 23;57(18):5016-5019. doi: 10.1002/anie.201800884. Epub 2018 Mar 23. PMID: 29451728.
Copy Download .nbib Format: NLM
Nanoscaled porphyrinic metal-organic frameworks: photosensitizer delivery systems for photodynamic therapy.

Journal of materials chemistry. B

Bůžek D, Zelenka J, Ulbrich P, Ruml T, Křížová I, Lang J, Kubát P, Demel J, Kirakci K, Lang K, Clark SG, Wallace RL.
PMID: 32263922
J Mater Chem B. 2017 Mar 07;5(9):1815-1821. doi: 10.1039/c6tb03230c. Epub 2017 Feb 16.

The photocytotoxic activity of porphyrin-containing materials including metal-organic frameworks (MOFs) has attracted ever increasing interest. We have developed a simple synthesis of hexagonal PCN-222/MOF-545 nanoparticles, which are powerful in inducing reactive oxygen species-mediated apoptosis of cancer cells upon visible...

Cite
Bůžek D, Zelenka J, Ulbrich P, et al. Nanoscaled porphyrinic metal-organic frameworks: photosensitizer delivery systems for photodynamic therapy. J Mater Chem B. 2017;5(9):1815-1821doi: 10.1039/c6tb03230c.
Bůžek, D., Zelenka, J., Ulbrich, P., Ruml, T., Křížová, I., Lang, J., Kubát, P., Demel, J., Kirakci, K., Lang, K., Clark, S. G., & Wallace, R. L. (2017). Nanoscaled porphyrinic metal-organic frameworks: photosensitizer delivery systems for photodynamic therapy. Journal of materials chemistry. B, 5(9), 1815-1821. https://doi.org/10.1039/c6tb03230c
Bůžek, Daniel, et al. "Nanoscaled porphyrinic metal-organic frameworks: photosensitizer delivery systems for photodynamic therapy." Journal of materials chemistry. B vol. 5,9 (2017): 1815-1821. doi: https://doi.org/10.1039/c6tb03230c
Bůžek D, Zelenka J, Ulbrich P, Ruml T, Křížová I, Lang J, Kubát P, Demel J, Kirakci K, Lang K, Clark SG, Wallace RL. Nanoscaled porphyrinic metal-organic frameworks: photosensitizer delivery systems for photodynamic therapy. J Mater Chem B. 2017 Mar 07;5(9):1815-1821. doi: 10.1039/c6tb03230c. Epub 2017 Feb 16. PMID: 32263922.
Copy Download .nbib Format: NLM
Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial.

Cancer

Nelson AM, Amonoo HL, Kavanaugh AR, Webb JA, Jackson VA, Rice J, Lavoie MW, Fathi AT, Brunner AM, Greer JA, Temel JS, El-Jawahri A, LeBlanc TW.
PMID: 34460937
Cancer. 2021 Dec 15;127(24):4702-4710. doi: 10.1002/cncr.33886. Epub 2021 Aug 30.

BACKGROUND: It has been shown previously that integrated palliative care for patients with acute myeloid leukemia (AML) during intensive chemotherapy leads to improvements in quality of life (QOL) and mood. Coping has been shown to mediate palliative care interventions...

Cite
Nelson AM, Amonoo HL, Kavanaugh AR, et al. Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial. Cancer. 2021;127(24):4702-4710doi: 10.1002/cncr.33886.
Nelson, A. M., Amonoo, H. L., Kavanaugh, A. R., Webb, J. A., Jackson, V. A., Rice, J., Lavoie, M. W., Fathi, A. T., Brunner, A. M., Greer, J. A., Temel, J. S., El-Jawahri, A., & LeBlanc, T. W. (2021). Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial. Cancer, 127(24), 4702-4710. https://doi.org/10.1002/cncr.33886
Nelson, Ashley M, et al. "Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial." Cancer vol. 127,24 (2021): 4702-4710. doi: https://doi.org/10.1002/cncr.33886
Nelson AM, Amonoo HL, Kavanaugh AR, Webb JA, Jackson VA, Rice J, Lavoie MW, Fathi AT, Brunner AM, Greer JA, Temel JS, El-Jawahri A, LeBlanc TW. Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial. Cancer. 2021 Dec 15;127(24):4702-4710. doi: 10.1002/cncr.33886. Epub 2021 Aug 30. PMID: 34460937; PMCID: PMC8664993.
Copy Download .nbib Format: NLM
Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy.

Ear, nose, & throat journal

Gorelik D, Frantz A, Dome JS, Reilly BK.
PMID: 34392730
Ear Nose Throat J. 2021 Aug 15;1455613211040578. doi: 10.1177/01455613211040578. Epub 2021 Aug 15.

Recurrent respiratory papillomatosis is a condition caused by human papilloma virus, usually sub types 6 and 11. Papillomas are benign neoplasms that are most commonly found on the larynx and can be often associated with significant airway involvement. Frequency...

Cite
Gorelik D, Frantz A, Dome JS, et al. Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy. Ear Nose Throat J. 2021;1455613211040578doi: 10.1177/01455613211040578.
Gorelik, D., Frantz, A., Dome, J. S., & Reilly, B. K. (2021). Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy. Ear, nose, & throat journal, 1455613211040578. https://doi.org/10.1177/01455613211040578
Gorelik, Daniel, et al. "Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy." Ear, nose, & throat journal vol. (2021): 1455613211040578. doi: https://doi.org/10.1177/01455613211040578
Gorelik D, Frantz A, Dome JS, Reilly BK. Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy. Ear Nose Throat J. 2021 Aug 15;1455613211040578. doi: 10.1177/01455613211040578. Epub 2021 Aug 15. PMID: 34392730.
Copy Download .nbib Format: NLM
Dealing With Death as an Outcome in Supportive Care Clinical Trials.

JAMA internal medicine

Halpern SD, Temel JS, Courtright KR.
PMID: 33970194
JAMA Intern Med. 2021 Jul 01;181(7):895-896. doi: 10.1001/jamainternmed.2021.1816.

No abstract available.

Cite
Halpern SD, Temel JS, Courtright KR. Dealing With Death as an Outcome in Supportive Care Clinical Trials. JAMA Intern Med. 2021;181(7):895-896doi: 10.1001/jamainternmed.2021.1816.
Halpern, S. D., Temel, J. S., & Courtright, K. R. (2021). Dealing With Death as an Outcome in Supportive Care Clinical Trials. JAMA internal medicine, 181(7), 895-896. https://doi.org/10.1001/jamainternmed.2021.1816
Halpern, Scott D, et al. "Dealing With Death as an Outcome in Supportive Care Clinical Trials." JAMA internal medicine vol. 181,7 (2021): 895-896. doi: https://doi.org/10.1001/jamainternmed.2021.1816
Halpern SD, Temel JS, Courtright KR. Dealing With Death as an Outcome in Supportive Care Clinical Trials. JAMA Intern Med. 2021 Jul 01;181(7):895-896. doi: 10.1001/jamainternmed.2021.1816. PMID: 33970194.
Copy Download .nbib Format: NLM
Modelling welfare estimates in discrete choice experiments for seaweed-based renewable energy.

PloS one

Mariel P, Demel S, Longo A.
PMID: 34843549
PLoS One. 2021 Nov 29;16(11):e0260352. doi: 10.1371/journal.pone.0260352. eCollection 2021.

We explore what researchers can gain or lose by using three widely used models for the analysis of discrete choice experiment data-the random parameter logit (RPL) with correlated parameters, the RPL with uncorrelated parameters and the hybrid choice model....

Cite
Mariel P, Demel S, Longo A. Modelling welfare estimates in discrete choice experiments for seaweed-based renewable energy. PLoS One. 2021;16(11):e0260352doi: 10.1371/journal.pone.0260352.
Mariel, P., Demel, S., & Longo, A. (2021). Modelling welfare estimates in discrete choice experiments for seaweed-based renewable energy. PloS one, 16(11), e0260352. https://doi.org/10.1371/journal.pone.0260352
Mariel, Petr, et al. "Modelling welfare estimates in discrete choice experiments for seaweed-based renewable energy." PloS one vol. 16,11 (2021): e0260352. doi: https://doi.org/10.1371/journal.pone.0260352
Mariel P, Demel S, Longo A. Modelling welfare estimates in discrete choice experiments for seaweed-based renewable energy. PLoS One. 2021 Nov 29;16(11):e0260352. doi: 10.1371/journal.pone.0260352. eCollection 2021. PMID: 34843549; PMCID: PMC8629263.
Copy Download .nbib Format: NLM
Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal.

Journal of the National Comprehensive Cancer Network : JNCCN

Chow R, Lage DE, Williams GR, Sedrak MS, Greer JA, Temel JS, Nipp RD.
PMID: 34991068
J Natl Compr Canc Netw. 2022 Jan;20(1):37-44. doi: 10.6004/jnccn.2021.7055.

BACKGROUND: Older adults account for 70% of cancer-related deaths, but previous studies have shown that they are underrepresented in cancer clinical trials. We sought to analyze the representation and outcomes of older adults in trials conducted in the era...

Cite
Chow R, Lage DE, Williams GR, et al. Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal. J Natl Compr Canc Netw. 2022;20(1):37-44doi: 10.6004/jnccn.2021.7055.
Chow, R., Lage, D. E., Williams, G. R., Sedrak, M. S., Greer, J. A., Temel, J. S., & Nipp, R. D. (2022). Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal. Journal of the National Comprehensive Cancer Network : JNCCN, 20(1), 37-44. https://doi.org/10.6004/jnccn.2021.7055
Chow, Ronald, et al. "Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal." Journal of the National Comprehensive Cancer Network : JNCCN vol. 20,1 (2022): 37-44. doi: https://doi.org/10.6004/jnccn.2021.7055
Chow R, Lage DE, Williams GR, Sedrak MS, Greer JA, Temel JS, Nipp RD. Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal. J Natl Compr Canc Netw. 2022 Jan;20(1):37-44. doi: 10.6004/jnccn.2021.7055. PMID: 34991068.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 67 entries